GluR2对视网膜变性过程中视杆双极细胞异常突起形成的作用及机制
结题报告
批准号:
81600758
项目类别:
青年科学基金项目
资助金额:
17.0 万元
负责人:
黄艳明
学科分类:
H1305.视网膜、脉络膜及玻璃体相关疾病
结题年份:
2019
批准年份:
2016
项目状态:
已结题
项目参与者:
袁容娣、张辰星、石小花、黄莉芸、范围、黄婵娟
国基评审专家1V1指导 中标率高出同行96.8%
结合最新热点,提供专业选题建议
深度指导申报书撰写,确保创新可行
指导项目中标800+,快速提高中标率
客服二维码
微信扫码咨询
中文摘要
双极细胞是光遗传学治疗视网膜变性疾病最理想的靶细胞,视网膜变性晚期双极细胞伸出异常突起严重阻碍其临床应用,因此探索双极细胞异常突起形成的机制并进行干预有重要意义。课题组预实验发现RCS大鼠变性晚期视杆双极细胞(RBs)伸出异常突起,表达mGluR6下降,可能表达AMPA受体。结合文献AMPA受体GluR2在其他视网膜变性动物RBs表达增加,以及GluR2在中枢神经系统的功能,我们推测视网膜变性过程中RBs上调GluR2表达促进异常突起形成。本课题拟从以下方面进行研究:⑴明确视网膜变性过程中GluR2与RBs异常突起的相关性;⑵在体实验下调RCS大鼠、上调正常大鼠GluR2表达观察对RBs突起生长的影响;⑶离体实验上调RBs中GluR2表达观察对突起生长的影响并初步探索其分子机制。本研究有助于明确视网膜变性中RBs异常突起形成的机制,为进一步探索抑制双极细胞异常突起形成的方法提供理论基础。
英文摘要
Bipolar cells are the ideal target cells of optogentic therapy for retinal degeneration (RD). Neuritogenesis of bipolar cells in late RD compromises optogentic therapy. Thus elucidating the mechanism of neuritogenesis of bipolar cells is impending. Our previous studies showed that rod bipolars (RBs) sprouted anomalous neuritogenesis in late RD in RCS rats. At the same time, mGluR6 was down regulated and AMPA was upregulated. Literature review revealed that GluR2 subunit of AMPA was upregulated in other RD models. And in the central nervous system, GluR2 play critical roles in the regulation of neurite outgrowth. We hypothesized that GluR2 upregulation promote anomalous neuritogenesis of RBs. In the present study, the correlation between GluR2 expression and anomalous neuritogenesis in RCS rats will be studied. Then GluR2 was up and downregulated in RCS and normal rats to study its role in dendrite growth of RBs in vivo. At last GluR2 was upreglated in primarily cultured retinal cells to further study its role in dendrite growth of RBs in vitro and the potential mechanism. The present study might help in elucidating the mechanisms underlying neuritogenesis of bipolar cells, and provide theoretical basis for exploring ways to inhibit neuritogenesis.
专著列表
科研奖励列表
会议论文列表
专利列表
国内基金
海外基金